Skip to main content
OpenTrials
Completed

NCT Number: NCT06515457

A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health

This study aims to evaluate the efficacy of BioNatureHealth's Eye Empower supplement in supporting vision and eye health. It is a virtual, single-group trial lasting 3 weeks. Participants will take three capsules of the supplement daily and complete questionnaires at Baseline, Week 1, Week 2, and Week 3 to assess visual clarity, dryness, symptoms of inflammation, and sensitivity to blue light.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female at birth, aged 40 or over
  • Self-reported concerns about at least two of the following symptoms: dry eyes, red/itchy/irritated eyes, sensitivity to blue light, blurred vision (far or near)
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid using new eye health prescriptions, over-the-counter medications, supplements, and herbal remedies for the study duration
  • Consistent use of current eye health supplements or herbal remedies for at least 3 months prior to the study
  • Willing to maintain current diet, sleep schedule, and activity level during the study

Exclusion criteria

  • Pre-existing chronic conditions preventing protocol adherence, including oncological and psychiatric disorders
  • Diagnosed diabetes (Type I or II)
  • Planning to undergo any eye-related procedures during the study
  • Recent surgeries or invasive treatments within the last six months
  • History of major illness within the last three months
  • Recent use of a supplement with active ingredients in the test product
  • Severe allergic reactions requiring an EpiPen, including shellfish allergy
  • Pregnant, breastfeeding, or planning to conceive
  • Use of medications or herbal supplements that impact the blood
  • Non-consumption of animal products for religious or personal reasons
  • Unwillingness to follow the study protocol
  • Anyone with a history of drug or alcohol abuse

Treatment and study plan

Eye Empower

Dietary Supplement

Participants will take three capsules of the Eye Empower supplement daily for three weeks.

Other names: BioNatureHealth Eye Empower

Primary outcomes

  1. Improvement in Visual Clarity

    Time frame: Baseline, Week 1, Week 2, and Week 3

    Participants will report on their visual clarity through self-reported questionnaires. The questionnaires will evaluate changes in visual clarity from baseline.

  2. Reduction in Eye Dryness

    Time frame: Baseline, Week 1, Week 2, Week 3

    Participants will self-report changes in eye dryness through questionnaires administered at specific intervals during the study. Parameters include the frequency and severity of dry eye symptoms.

  3. Reduction in Symptoms of Inflammation

    Time frame: Baseline, Week 1, Week 2, Week 3

    Participants will self-report changes in symptoms of eye inflammation through questionnaires administered at specific intervals during the study. Parameters include redness, irritation, and discomfort.

  4. Reduction in Sensitivity to Blue Light

    Time frame: Baseline, Week 1, Week 2, Week 3

    Participants will self-report changes in sensitivity to blue light through questionnaires administered at specific intervals during the study. Parameters include the degree of discomfort experienced when exposed to blue light from screens and other sources.

Secondary outcomes

  1. Improvement in Overall Eye Health

    Time frame: Baseline, Week 1, Week 2, and Week 3

    Participants will report on their overall eye health through self-reported questionnaires. The questionnaires will assess changes in symptoms such as eye dryness, symptoms of inflammation, and sensitivity to blue light.

Sponsors and collaborators

Lead sponsor

Bio Nature Health

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 23, 2024
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.